Stoke Therapeutics Stock Price Patterns
| STOK Stock | USD 31.07 1.67 5.68% |
Momentum 46
Impartial
Oversold | Overbought |
Using Stoke Therapeutics hype-based prediction, you can estimate the value of Stoke Therapeutics from the perspective of Stoke Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Stoke Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Stoke because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Stoke Therapeutics after-hype prediction price | USD 31.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Stoke Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.Stoke Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Stoke Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Stoke Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Stoke Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Stoke Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Stoke Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Stoke Therapeutics' historical news coverage. Stoke Therapeutics' after-hype downside and upside margins for the prediction period are 26.46 and 35.68, respectively. We have considered Stoke Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Stoke Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Stoke Therapeutics is based on 3 months time horizon.
Stoke Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Stoke Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Stoke Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Stoke Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 4.61 | 0.00 | 0.03 | 0 Events / Month | 4 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
31.07 | 31.07 | 0.00 |
|
Stoke Therapeutics Hype Timeline
Stoke Therapeutics is at this time traded for 31.07. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. Stoke is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.16%. %. The volatility of related hype on Stoke Therapeutics is about 2845.68%, with the expected price after the next announcement by competition of 31.04. About 96.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.27. Stoke Therapeutics had not issued any dividends in recent years. The entity had 1:9 split on the 6th of June 2019. Given the investment horizon of 90 days the next estimated press release will be within a week. Check out Stoke Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.Stoke Therapeutics Related Hype Analysis
Having access to credible news sources related to Stoke Therapeutics' direct competition is more important than ever and may enhance your ability to predict Stoke Therapeutics' future price movements. Getting to know how Stoke Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Stoke Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NTLA | Intellia Therapeutics | 0.00 | 0 per month | 6.09 | 0.05 | 10.12 | (7.99) | 33.96 | |
| UPB | Upstream Bio | (1.45) | 9 per month | 3.40 | 0.13 | 7.87 | (5.24) | 24.37 | |
| ARDX | Ardelyx | 0.44 | 8 per month | 2.70 | 0.14 | 10.57 | (4.91) | 29.66 | |
| SYRE | Spyre Therapeutics | 0.00 | 0 per month | 2.36 | 0.14 | 7.15 | (3.87) | 20.03 | |
| WVE | Wave Life Sciences | 0.45 | 8 per month | 4.04 | 0.1 | 8.92 | (6.68) | 164.47 | |
| ZYME | Zymeworks Common Stock | (1.14) | 13 per month | 2.71 | 0.08 | 5.40 | (4.49) | 36.09 | |
| PHVS | Pharvaris BV | 0.00 | 0 per month | 3.34 | 0.09 | 6.58 | (6.01) | 27.81 | |
| NVAX | Novavax | 0.04 | 9 per month | 2.95 | 0.04 | 6.10 | (5.54) | 26.68 | |
| BCRX | BioCryst Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.06) | 4.49 | (4.55) | 16.75 | |
| ZBIO | Zenas BioPharma Common | 0.04 | 10 per month | 11.16 | 0.03 | 13.19 | (8.49) | 84.91 |
Stoke Therapeutics Additional Predictive Modules
Most predictive techniques to examine Stoke price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Stoke using various technical indicators. When you analyze Stoke charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Stoke Therapeutics Predictive Indicators
The successful prediction of Stoke Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Stoke Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Stoke Therapeutics based on analysis of Stoke Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Stoke Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Stoke Therapeutics's related companies.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Stoke Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Stoke Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Stoke Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Stoke Therapeutics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Stoke Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Stoke Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.